Sort
21,281 grants matching “influenza”
Host-targeted antivirals for influenza and other respiratory virus infections
$251,424Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · R21 · FY2013 · AI
Career Enhancement Core - CEC
$251,421Wendy Lynet Bennett · Johns Hopkins University · U54 · FY2022 · AG
RII Track-4: The Molecular Nature of Environmentally Persistent Free Radicals on Nanoparticles
$251,321Eric P Vejerano · University Of South Carolina At Columbia · · FY2017 · O/D
Transgenic Aminal Core
$251,317Jeffrey Victor Ravetch · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2020 · AI
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTS
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · AG
Host response-based screening for unexpected or emerging respiratory viruses
$251,250Ellen Flescher Foxman · Yale University · R21 · FY2022 · AI
Interplay between canonical and non-canonical interferons in defense against respiratory viruses
$251,250Ellen Flescher Foxman · Yale University · R21 · FY2024 · AI
Suppression of the type I IFN gene signature by the long non-coding RNA-Lucat-1
$251,250Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
Age-Associated B Cells Specialized for Immunity to Pathogens?
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AG
Modeling human anti-viral humoral responses in the young and elderly
$251,250Robert Thomas Woodland · Univ Of Massachusetts Med Sch Worcester · R21 · FY2015 · AI
Inc'ing RNA to anti-viral defense
$251,250Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
Atypical B Cells: Origin and Autoreactivity
$251,250Joseph E Craft · Yale University · R21 · FY2024 · AI
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AI
Signal cell seqencing of primary HCMV infections
$251,250Timothy F Kowalik · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI
Semantic Integration of ImmPort and the Linked Data Cloud for Systems Vaccinology
$251,250Steven H. Kleinstein · Yale University · UH2 · FY2018 · AI
Protective function of virus-induced age-associated B cells
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · AI
Discovery of NR4A1/2 ligands controlling tissue-resident memory T (Trm) cells
$251,250Susan M Kaech · Yale University · R21 · FY2017 · AI
Maintaining Robust T Cell Immunity For Broad Protection Against Influenza
$251,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
Novel brain-penetrant fusion inhibitors for control of CNS infection.
$251,245Matteo Porotto · Weill Medical Coll Of Cornell Univ · R21 · FY2011 · NS
STRUCTURE/FUNCTION OF THE INFLUENZA VIRUS GENOME
$251,205Robert A Lamb · Northwestern University · R37 · FY2006 · AI
SBIR Phase I: Hemagglutinin-specific affinity capture membrane for rapid purification of influenza vaccines
$251,170Graham Temples · Purilogics, Llc · R43 · FY2020 · AI
Shikimate Pathway Variants
$251,160Michigan State University · R01 · FY2004 · GM
Shikimate Pathway Variants
$251,160Michigan State University · R01 · FY2005 · GM
IMMUNOGLOBULIN HCDR3 IN AUTOIMMUNE DISEASE
$251,125University Of Alabama At Birmingham · R01 · FY2003 · AI